Columbia Laboratories, a specialty pharmaceutical company, has appointed Anthony Campbell to its board of directors.
Subscribe to our email newsletter
Mr Campbell is a manager and senior analyst for Dorset Management and a member of Knott Partners Management. Mr Campbell holds a BS degree from McGill University.
Mr Campbell is an independent director under the current NASDAQ national market listing standards and brings to seven the number of independent directors on the company’s eight-person board. Mr Campbell is expected to serve on the board’s audit committee and scientific committee.
Bob Mills, president and CEO of Columbia Laboratories, said: “Tony brings valuable experience in advising public companies in the life sciences industry and can contribute significantly to our company.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.